<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, some advanced therapy is available at few centers in the Middle East [
 <xref rid="ref011" ref-type="bibr">11</xref>]. While the availability of neurosurgical stereotactic procedures and drug-infusion therapies were not available in many countries according to respondents, the practice of DBS is growing with some challenges, not only regarding its cost but also the lack of well-trained experts to manage it. This also applies to infusion therapies, which are less commonly available, even in specialized centers. This is likely in part due to the significant maintenance costs [
 <xref rid="ref052" ref-type="bibr">52</xref>]. As these advanced therapies become increasingly available, their healthcare providers must be proficient regarding candidacy for these therapies [
 <xref rid="ref073" ref-type="bibr">73</xref>]. Future work is needed to characterize the availability of drugs and which medications are prescribed/used, cost considerations, and access to advanced therapies in the MENASA region.
</p>
